Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
62.82
+0.34 (0.54%)
At close: May 18, 2026, 4:00 PM EDT
63.00
+0.18 (0.29%)
After-hours: May 18, 2026, 5:42 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $2.7 billion as of May 18, 2026. Its market cap has increased by 27.89% in one year.
Market Cap
2.70B
Enterprise Value
2.40B
1-Year Change
27.89%
Ranking
Category
Stock Price
$62.82
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $2.70B, an increase of 777.11%. That is a compound annual growth rate of 47.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 2.69B | -22.66% |
| Dec 31, 2025 | 3.48B | 64.21% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 2.94B |
| Denali Therapeutics | 2.92B |
| Soleno Therapeutics | 2.76B |
| Dyne Therapeutics | 2.73B |
| Alumis | 2.70B |
| Beam Therapeutics | 2.67B |
| Structure Therapeutics | 2.57B |
| Disc Medicine | 2.55B |